Back
BridgeBio Pharma Stock Price Chart
Sponsored
BBIO
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53
BBIO
BridgeBio Pharma
Last Price:
23.27
Seasonality Move:
7.7%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBIO is experiencing slight buying pressure.
BridgeBio Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.55 | Sell |
20-day SMA: | 24.46 | Sell |
50-day SMA: | 25.03 | Sell |
200-day SMA: | 27.35 | Sell |
8-day EMA: | 23.58 | Sell |
20-day EMA: | 24.28 | Sell |
50-day EMA: | 24.98 | Sell |
200-day EMA: | 26.51 | Sell |
BridgeBio Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.57 | Sell |
Relative Strength Index (14 RSI): | 41.84 | Sell |
Chaikin Money Flow: | 76532 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.41 - 25.71) | Sell |
Bollinger Bands (100): | (24.02 - 27.4) | Sell |
BridgeBio Pharma Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BridgeBio Pharma Stock
Is BridgeBio Pharma Stock a Buy?
- BridgeBio Pharma share price is 23.24 while BBIO 8-day simple moving average is 23.55, which is a Sell signal.
- The stock price of BBIO is 23.24 while BridgeBio Pharma 20-day SMA is 24.46, which makes it a Sell.
- BridgeBio Pharma 50-day simple moving average is 25.03 while BBIO share price is 23.24, making it a Sell technically.
- BBIO stock price is 23.24 and BridgeBio Pharma 200-day simple moving average is 27.35, creating a Sell signal.
BBIO Technical Analysis vs Fundamental Analysis
Buy
53
BridgeBio Pharma (BBIO)
is a Buy
Is BridgeBio Pharma a Buy or a Sell?
-
BridgeBio Pharma stock is rated a Buy
The current BridgeBio Pharma [BBIO] share price is $23.24. The Score for BBIO is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
BridgeBio Pharma Stock Info
Market Cap:
4.39B
Price in USD:
23.24
Share Volume:
2.07M
BridgeBio Pharma 52-Week Range
52-Week High:
44.32
52-Week Low:
21.62
Buy
53
BridgeBio Pharma (BBIO)
is a Buy
BridgeBio Pharma Share Price Forecast
-
What is the BridgeBio Pharma stock price today?
The BridgeBio Pharma stock price is 23.24 USD today. -
Will BBIO stock go up or go down?
BridgeBio Pharma> share price is forecast to RISE/FALL based on technical indicators -
Is BridgeBio Pharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, BridgeBio Pharma is not overvalued.
Is BridgeBio Pharma Stock a Buy?
- BridgeBio Pharma share price is 23.24 while BBIO 8-day exponential moving average is 23.58, which is a Sell signal.
- The stock price of BBIO is 23.24 while BridgeBio Pharma 20-day EMA is 24.28, which makes it a Sell.
- BridgeBio Pharma 50-day exponential moving average is 24.98 while BBIO share price is 23.24, making it a Sell technically.
- BBIO stock price is 23.24 and BridgeBio Pharma 200-day simple moving average is 26.51, creating a Sell signal.
Fundamental Analysis of BridgeBio Pharma
Is BridgeBio Pharma a good investment?
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.35 per share, and a decrease next year of $2.41 per share.
Technical Analysis of BridgeBio Pharma
Should I short BridgeBio Pharma stock?
- BBIO Moving Average Covergence Divergence (MACD) indicator is -0.57, suggesting BridgeBio Pharma is a Sell
- BridgeBio Pharma Relative Strength Index (RSI) is 41.84, which suggest BridgeBio Pharma is oversold
- The Bollinger Bands (25) for BridgeBio Pharma is (23.41 - 25.71), which suggest BridgeBio Pharma is a Sell
- The Bollinger Bands (100) for BridgeBio Pharma is (24.02 - 27.4), which suggest BridgeBio Pharma is a Sell
* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.